Source study found
Story checked
Second-ever case of rare fungus resistant to four antifungal drug classes detected in Kenya (opens in a new tab)
medicalxpress.com · 2026-10-19
Short answer
Needs reviewStudy found.
We found the study, but the claim check did not finish.
Share this check
The story
Second-ever case of rare fungus resistant to four antifungal drug classes detected in Kenya
medicalxpress.com · 2026-10-19
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
We found the study behind this story.
We found the study, but couldn't compare the story to it: the study's evidence could not be profiled.
Open claim evidenceThe source study
Emergence of pan-drug resistant Candidozyma auris in Kenya, the second globally documented case
Evidence layer
Claim by claim
The source study was found, but the study's evidence could not be profiled, so these claims couldn't be checked.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 4Not checkedA recent study uncovered an extremely rare fungal strain that can withstand all four major classes of antifungal drugs—azoles, echinocandins, polyenes and flucytosine.View evidenceHide evidence
As statedall four major classes
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 2 of 4Not checkedResearchers isolated the pan-drug-resistant strain from a 28-year-old patient who developed a surgical wound infection while hospitalized in Nairobi, Kenya.View evidenceHide evidence
As stated28-year-old patient
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 3 of 4Not checkedThis is the first time a pan-drug-resistant strain of the fungus has been identified in Africa and only the second documented case worldwide; the first case was reported in New York.View evidenceHide evidence
As statedfirst time in Africa; second documented case worldwide
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 4 of 4Not checkedGenetic testing traced the fungus to a lineage already circulating in Kenya and identified a specific combination of drug-resistance mutations that could explain why the antifungal medicines failed.View evidenceHide evidence
Not checked
The source study was found, but this claim couldn't be checked against it.
Method layer
NewsLink found the paper. Tessa takes you deeper.
NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.
Open the paper in Tessa
Emergence of pan-drug resistant Candidozyma auris in Kenya, the second globally documented case
Scientific Reports · 2026
Why this one
Near certain
NewsLink found the paper. Tessa is where you inspect it deeply.
Papers considered
The selected paper, plus nearby candidates.
Crossref, Europe PMC, PubMed · 40 candidate papers
Emergence of pan-drug resistant Candidozyma auris in Kenya, the second globally documented case
Scientific Reports · 2026 · Crossref
Genomic epidemiology of coxsackievirus A24 variant during the 2024 acute hemorrhagic conjunctivitis outbreak in Coastal Kenya.
2026 · Europe PMC
An Integrated IoT and Forensic Framework for Institutional Arson Mitigation in Boarding Facilities
International Journal of Research and Scientific Innovation · 2026 · Crossref
Keloids as a rare complication of voluntary medical male circumcision: findings from PEPFAR's notifiable adverse events reporting system.
2026 · Europe PMC
Author Correction: Inference limits in partially observable Ethereum blockchains
Scientific Reports · 2026 · Crossref
Molecular Epidemiology of Human Metapneumovirus in Kilifi, Coastal Kenya, 2016-2017 and 2021-2024.
2026 · Europe PMC
And 34 more candidates considered.